Evidence map›Paper›PMID 30873438›Full record

ArticleSynthetic biology (Oxford, England)2019

Cell-free biosynthesis of limonene using enzyme-enriched

Quentin M Dudley, Connor J Nash, Michael C Jewett

Open access · goldAbstract read
In one paragraph

Article in Synthetic biology (Oxford, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. A Rapid and Modular Nanobody Assay for Plug-and-Play Antigen Detection.bioRxiv : the preprint server for biology · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Rewiring cell-free metabolic flux inSynthetic biology (Oxford, England) · 2023
    Article
  14. Article
  15. Monoterpenoid biosynthesis by engineered microbes.Journal of industrial microbiology & biotechnology · 2021
    Review
  16. A roadmap for metagenomic enzyme discovery.Natural product reports · 2021
    Review
  17. Article
  18. A Modular In Vitro Platform for the Production of Terpenes and Polyketides from COAngewandte Chemie (International ed. in English) · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Quentin M DudleyDepartment of Chemical and Biological Engineering, Northwestern University, Evanston, IL, USA.
Connor J NashDepartment of Chemical and Biological Engineering, Northwestern University, Evanston, IL, USA.
Michael C JewettDepartment of Chemical and Biological Engineering, Northwestern University, Evanston, IL, USA.
Northwestern University · US

Funding

Molecular Biophysics Training Program at Northwestern UniversityT32GM008382 · NIGMS · NORTHWESTERN UNIVERSITY · PI RADHAKRISHNAN, ISHWAR · 1990 to 2020
$4.3M
NIGMS NIH HHS T32 GM008382
6 · The paper itself

Abstract

Isoprenoids are an attractive class of metabolites for enzymatic synthesis from renewable substrates. However, metabolic engineering of microorganisms for monoterpenoid production is limited by the need for time-consuming, and often non-intuitive, combinatorial tuning of biosynthetic pathway variations to meet design criteria. Towards alleviating this limitation, the goal of this work was to build a modular, cell-free platform for construction and testing of monoterpenoid pathways, using the fragrance and flavoring molecule limonene as a model. In this platform, multiple

Indexed as

cell-free metabolic engineeringcell-free synthetic biologyE. coli crude lysatelimonenemetabolic pathway prototyping

Identifiers

PMID30873438
PMCPMC6407499
OpenAlexW2910553151

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.